マルヤマ　タカシ   MARUYAMA Takashi   丸山　隆志    所属   医学部 医学科（東京女子医科大学病院）    職種   非常勤講師
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
掲載誌名	正式名：Journal of neurosurgery 略　 称：J Neurosurg ISSNコード：00223085
巻・号・頁	121(3),pp.543-553
著者・共著者	ISHIKAWA Eiichi†, MURAGAKI Yoshihiro, YAMAMOTO Tetsuya, MARUYAMA Takashi, TSUBOI Koji, IKUTA Soko, HASHIMOTO Koichi, UEMAE Youji, ISHIHARA Takeshi, MATSUDA Masahide, MATSUTANI Masao, KARASAWA Katsuyuki, NAKAZATO Yoichi, ABE Tatsuya, OHNO Tadao, MATSUMURA Akira
発行年月	2014/09
概要	Temozolomide (TMZ) may enhance antitumor immunity in patients with glioblastoma multiforme (GBM). In this paper the authors report on a prospective Phase I/IIa clinical trial of fractionated radiotherapy (FRT) concomitant with TMZ therapy, followed by treatment with autologous formalin-fixed tumor vaccine (AFTV) and TMZ maintenance in patients with newly diagnosed GBM.
DOI	10.3171/2014.5.jns132392
文献番号	24995786